Clinical Trials on Substance Withdrawal Syndrome

Total 41890 results

Mahidol University
Siriraj Hospital

Recruiting

Urea Cream Prevention for Capecitabine Associated Hand Foot Syndrome

Hand-Foot Syndrome

Thailand
Cook County Health

Terminated

Vitamin B6 Can Prevent Hand and Foot Syndrome in Cancer Patients Capecitabine Chemotherapy

Hand and Foot Syndrome

United States
Fundació Institut de Recerca de l'Hospital de la...

Completed

Effectiveness Allopurinol Topical Agent Prevention Capecitabine-induced Hand-foot Syndrome

Hand-foot Syndrome

Spain
Asan Medical Center

Completed

Study of Pyridoxine for Hand-Foot Syndrome

Hand-foot Syndrome
Benjamin Tomlinson

Recruiting

5-Azacitidine and Decitabine Epigenetic Therapy for Myeloid Malignancies

Myelodysplastic Syndromes | MDS/MPN Crossover Syndromes

United States
Texas Tech University Health Sciences Center

Terminated

Evaluating the Efficacy of a Video Based Intervention to Educate Teen Moms About Fetal Alcohol Syndrome (FAS)

Teen Pregnancy | Fetal Alcohol Syndrome

United States
China Medical University Hospital

Not yet recruiting

The Efficacy of Acupuncture and Laser Acupuncture in Treating Chemotherapy or Target Therapy-induced Hand-foot Syndrome

Hand-Foot Syndrome
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

The Efficacy and Safety of Mecobalamin in the Prevention of Capecitabine Induced Hand Foot Syndrome

Hand-foot Syndrome

China
Instituto Brasileiro de Controle do Cancer
Wecare Comércio de Cosméticos

Recruiting

Hydration Based on Thoitaine, Aloe Vera and Calendula, in the Prevention of Hand-Foot Syndrome in Patients Using Capecitabine (TACX Care)

Hand-foot Syndrome

Brazil
Nan xu

Completed

Acetylated Natural Nucleotides in Treating Hand-foot Syndrome

Hand-foot Syndrome

China
Heinrich-Heine University, Duesseldorf

Terminated

The Effect of Topical Brimonidine Tartrate on Hand-foot Syndrome (HFS) in Cancer Patients (BRIMOCAN)

Hand-foot Syndrome

Germany
M.D. Anderson Cancer Center

Recruiting

A Pilot Study for Pupillary Assessment to Predict CAR-T Related Neurotoxicity

Neurotoxicity

United States
University of Medicine and Dentistry of New Jersey

Terminated

A Pilot Study of Dextromethorphan for the Prevention and Treatment of Methotrexate Neurotoxicity

Neurotoxicity Syndromes

United States
Fred Hutchinson Cancer Center
Swedish Orphan Biovitrum

Recruiting

Anakinra for the Prevention of Cytokine Release Syndrome and Neurotoxicity in Patients With B-Cell Non-Hodgkin Lymphoma Receiving CD19-Targeted CAR-T Cell Therapy

B-Cell Non-Hodgkin Lymphoma

United States
Dana-Farber Cancer Institute

Completed

The Myelodysplasia Transplantation-Associated Outcomes (MDS-TAO) Study

Myelodysplastic Syndromes (MDS)

United States
Haukeland University Hospital

Unknown

Does Serum-DXM Increase Diagnostic Accuracy of the Overnight DXM Suppression Test in the Work-up of Cushing's Syndrome? (DXM)

Alcoholism | Obesity | Cushing's Syndrome | Adrenal Incidentalomas

Norway
Henry Ford Health System

Unknown

Adjunct Methadone to Decrease the Duration of Mechanical Ventilation in the Medical Intensive Care Unit

Delirium | Opioid-Induced Disorders | Opioid Use, Unspecified With Withdrawal

United States
Wendy F Hansen
Patient-Centered Outcomes Research Institute

Active, not recruiting

The PATH Home Trial: A Comparative Effectiveness Study of Peripartum Opioid Use Disorder in Rural Kentucky (PATH)

Neonatal Abstinence Syndrome

United States
Albert Einstein College of Medicine

Completed

Studies of Sulfur Metabolism in Humans

Metabolic Side Effects of Drugs

United States
Gerald Higa, PharmD.

Terminated

Study to Assess Prevention of Oxaliplatin-induced Neurotoxicity Through Vitamin D Pathway

Neurotoxicity

United States
University College Cork

Unknown

Discontinuation of Long-term Medications in Older People Entering Nursing Home Care (STOPPFrail)

Frail Elderly Syndrome | Drug-Related Side Effects and Adverse Reactions | Polypharmacy | Inappropriate Prescribing

Ireland
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Family Engagement, Cross-System Linkage to Substance Use Treatment for Juvenile Probationers -- Phase 3

Substance-Related Disorders | Substance Use | Substance Use Disorders | Substance Abuse | Substance Dependence | Substance Related Problem
University of Southern California

Enrolling by invitation

Cyclosporine vs Steroids in DRESS

DRESS Syndrome | Drug-Induced Hypersensitivity Syndrome

United States
Massachusetts General Hospital

Completed

Fetal Alcohol Damage Prevention Study

Substance Abuse | Fetal Alcohol Syndrome

United States
University of Miami

Completed

Trauma Intervention for Affect Regulation, AIDS, and Substances (TIARAS)

Post Traumatic Stress Disorder | Human Immunodeficiency Virus | Substance Related Disorder

United States
Advancell - Advanced In Vitro Cell Technologies...
Cromsource

Completed

Safety and Efficacy Placebo Controlled Study of ATH008 Cream in PPES Patients Secondary to Capecitabine

Palmar-Plantar Erythrodysesthesia Syndrome

Spain, Belgium, Germany, Italy
Radboud University Medical Center

Recruiting

A Prospective, Multicentre European Registry for Newly Diagnosed Patients With Myelodysplastic Syndromes (EUMDS)

Myelodysplastic Syndromes (MDS)

Denmark, Switzerland, Serbia, Austria, Croatia, Czechia, France, Germany, Greece, Israel, Italy, Netherlands, Poland, Portugal, Romania, Spain, Sweden, United Kingdom
Takeda

Withdrawn

A Study of Pevonedistat Combined With Decitabine and Cedazuridine in Adults With Higher-risk Myelodysplastic Syndromes (PEVOBINE)

Myelodysplastic Syndromes (MDS)
University of Pennsylvania
National Cancer Institute (NCI); Northwestern University

Recruiting

Optimizing Tobacco Use Treatment for PLWHA (HTO)

HIV/AIDS | Nicotine Dependence

United States
Prof. Janet Dunn
King's College Hospital NHS Trust; University of Manchester; University of Birmingham and other collaborators

Recruiting

Repurposed Drugs to Improve Haematological Responses in Myelodysplastic Syndromes (REPAIR-MDS)

Myelodysplastic Syndromes (MDS)

United Kingdom
The Cleveland Clinic

Withdrawn

Can The Bridge Transition Opiate Use Disorder Patients in Stable Recovery From Buprenorphine to Naltrexone

Substance Use | Substance Use Disorders | Substance Abuse | Substance Dependence

United States
Aston University

Not yet recruiting

Protecting the Eyes of Gamers With Lubricating Eyedrops (PROTEGE)

Dry Eye Syndromes | Computer Vision Syndrome
Children's National Research Institute

Completed

Sound Levels in the Pediatric Cardiac Critical Care Unit and Their Correlation With Sedation Administration, Delirium Scores and Patient Heart Rate

Noise Exposure | Sedative Toxicity | Sedative Withdrawal Delirium

United States
Nova Southeastern University
Centers for Disease Control and Prevention

Completed

A Media Based Motivational Intervention to Prevent Alcohol Exposed Pregnancies (AEPs)

Alcohol Consumption | Students | Fetal Alcohol Syndrome Disorders

United States
Rigel Pharmaceuticals

Recruiting

Study of R289 in Participants With Lower-risk Myelodysplastic Syndromes (LR MDS)

Low Risk Myelodysplastic Syndromes

United States
Bristol-Myers Squibb

Active, not recruiting

Real-World Practice Patterns and Outcomes of Lower-Risk Myelodysplastic Syndrome Patients in Japan

Lower-risk Myelodysplastic Syndromes

Japan
Istanbul University

Completed

Effects of Core Stabilization Exercises on Pulmonary Functions, Respiratory Muscle Strength and Functional Capacity

Substance Use | Substance Use Disorders | Substance Abuse

Turkey
Akeso

Recruiting

A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes

Higher-risk Myelodysplastic Syndromes

United States, China
Nuwacell Biotechnologies Co., Ltd.
The First Affiliated Hospital of University of Science and Technology of...

Not yet recruiting

A Trial to Evaluate the Safety and Efficacy of NK Cells in Subjects With Myelodysplastic Syndromes

Relapsed / Refractory Myelodysplastic Syndromes
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Terminated

CPI-613 in Treating Patients With Myelodysplastic Syndromes Who Failed Previous Therapy

Previously Treated Myelodysplastic Syndromes

United States
Oulu University Hospital

Unknown

Assessment of Chemotherapy-induced Peripheral Neurotoxicity Using a Point-of-care Nerve Conduction Study Device (APPS)

Cancer

Finland
The University of Queensland
Royal Brisbane and Women's Hospital

Unknown

Exercise in Critically Ill Patients With Sepsis

Sepsis Syndromes

Australia
University of Colorado, Denver

Active, not recruiting

Omacetaxine + Azacitidine in Untreated Patients With High Grade MDS

High Grade Myelodysplastic Syndromes

United States
ALX Oncology Inc.

Active, not recruiting

A Study of Evorpacept (ALX148) With Azacitidine for Higher Risk Myelodysplastic Syndrome (ASPEN-02)

Higher Risk Myelodysplastic Syndromes

Korea, Republic of, United States, Spain
State University of New York - Upstate Medical...
University at Buffalo

Completed

Neuropsychoanalytic Treatment of Failed Back Surgery Syndrome-Opioid Dependence

Pain
VA Office of Research and Development
VA Ann Arbor Healthcare System

Recruiting

Developing a Telehealth Model to Improve Treatment Access for Rural Veterans With Substance Use Disorders (VetReach)

Substance Use | Substance Use Disorders | Substance Dependence | Veterans

United States
The University of Texas Health Science Center,...

Recruiting

Identifying Correlates of Brain Microglial Activation in Neuropsychiatric Syndromes: A Dimensional Approach

Neuropsychiatric Syndromes

United States
Groupe Francophone des Myelodysplasies

Unknown

Treatment of the Anemia of Myelodysplastic Syndromes by the Association of Epoetin Beta and All Trans Retinoic Acid

Anemia in Myelodysplastic Syndromes

France
University of Arizona

Recruiting

tDCS and Impulsivity

Substance Use | Substance Use Disorders | Substance Abuse

United States
University of Calgary
Canadian Institutes of Health Research (CIHR)

Completed

Treatment Strategies in CHS (HALO)

Cannabis Hyperemesis Syndrome

Canada

Clinical Trials on Substance Withdrawal Syndrome

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gabon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations